All Stories

Stealth biotech bags rights to VelaVigo bispecific in $440M deal

VelaVigo Bio has landed its second deal in six months, offloading ex-China rights to a bispecific to Ollin Biosciences for up to $440 million.

Apr 18, 2025 - 12:52
 0
Stealth biotech bags rights to VelaVigo bispecific in $440M deal
VelaVigo Bio has landed its second deal in six months, offloading ex-China rights to a bispecific to Ollin Biosciences for up to $440 million.
Read More

Tags:

Previous Article

Latin America: Unlocking multimobility

Next Article

VALENTINO reports 2024 revenues down 2 percent

Related Posts

Chutes & Ladders—NIH leaders join health agency exodus

Chutes & Ladders—NIH leaders join health agency exodus

Feb 21, 2025  0

Boston biotech Bambusa banks $90M for next-gen bispecifics

Boston biotech Bambusa banks $90M for next-gen bispecifics

Feb 14, 2025  0

Synchron and Nvidia set sights on AI model trained by direct brain activity

Synchron and Nvidia set sights on AI model trained by d...

Mar 19, 2025  0